Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001175550 | SCV001339174 | likely pathogenic | X-linked intellectual disability, Cantagrel type | 2020-12-18 | criteria provided, single submitter | clinical testing | Variant summary: NEXMIF c.2091_2113del23 (p.Asp698ArgfsX5) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 204232 control chromosomes (gnomAD). To our knowledge, no occurrence of c.2091_2113del23 in individuals affected with Mental retardation, X-linked 98 and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. |